UBS Group »

Amneal Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 178k 6.06
2023-12-31 $1.1M 174k 6.07
2023-09-30 $289k 68k 4.22
2023-06-30 $37k 12k 3.10
2023-03-31 $7.3k 5.2k 1.39
2022-12-31 $38k 19k 1.99
2022-09-30 $55k 27k 2.06
2022-06-30 $35k 11k 3.14
2022-03-31 $52k 12k 4.19
2021-12-31 $178k 37k 4.76
2021-09-30 $59k 11k 5.36
2021-06-30 $103k 20k 5.09
2021-03-31 $74k 11k 6.73
2020-12-31 $246k 54k 4.55
2020-09-30 $165k 42k 3.91
2020-06-30 $386k 81k 4.74
2020-03-31 $43k 12k 3.48
2019-12-31 $27k 5.5k 4.91
2019-09-30 $22k 7.6k 2.88
2019-06-30 $167k 23k 7.18
2019-03-31 $562k 41k 13.57
2018-12-31 $1.0M 75k 13.57
2018-09-30 $954k 50k 19.11
2018-06-30 $932k 57k 16.42